• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

前列腺癌根治术后游离及总前列腺特异性抗原的血清半衰期测定——一项批判性评估

Serum half-life time determination of free and total prostate-specific antigen following radical prostatectomy--a critical assessment.

作者信息

Brändle E, Hautmann O, Bachem M, Kleinschmidt K, Gottfried H W, Grünert A, Hautmann R E

机构信息

Department of Urology, University of Ulm, Germany.

出版信息

Urology. 1999 Apr;53(4):722-30. doi: 10.1016/s0090-4295(98)00593-7.

DOI:10.1016/s0090-4295(98)00593-7
PMID:10197847
Abstract

OBJECTIVES

All studies investigating the elimination kinetics of serum total (tPSA) and free (fPSA) prostate-specific antigen (PSA) were carried out in men undergoing radical prostatectomy. Radical prostatectomy itself could, however, have a major influence on the serum concentration of these tumor markers (e.g., perioperative fluid shift or blood loss). The purpose of our study was to determine the half-life time of fPSA and tPSA with special regard to the influence of the radical prostatectomy on the serum concentration of these tumor markers.

METHODS

Eleven men (mean age 63.2+/-7.2 years) with organ-confined prostate cancer who underwent radical prostatectomy were investigated (final pathologic Stage pT2pN0 or lower). Serum samples were obtained preoperatively and 0.25, 0.5, 1, 2, 4, 8, 12, 16, 24, 48, 72, 120, 168, and 240 hours after removal of the prostate. fPSA and tPSA and albumin and total protein serum concentrations were determined in all samples.

RESULTS

During the first 120 minutes after removal of the prostate, albumin and total protein serum concentrations continuously declined, with a half-life time of -104.5+/-28 minutes and -129.7+/-32 minutes, respectively. Serum decline of fPSA and tPSA followed a biphasic kinetic. During the initial alpha-phase, fPSA and tPSA serum concentrations decreased, with a half-life time of -69+/-10.3 minutes and -87.3+/-18.1 minutes, respectively. During the terminal beta-phase, the half-life time of fPSA and tPSA was -1152.2 minutes (0.8 days) and -3916.1 minutes (2.7 days), respectively. Between the alpha-phase half-life time of fPSA or tPSA and the half-life time of the total protein or albumin concentration decline, significant correlations were found.

CONCLUSIONS

These correlations indicate that the rapid decline of fPSA and tPSA directly after removal of the prostate (alpha-phase half-life time) is caused by the radical prostatectomy itself. The half-life time of the beta-phase reflects the biologic clearance of PSA. Therefore, the half-life time determination of PSA after radical prostatectomy is of limited value if the influence of the operation itself on the serum PSA concentration is not taken into account.

摘要

目的

所有研究血清总前列腺特异性抗原(tPSA)和游离前列腺特异性抗原(fPSA)消除动力学的研究均在接受根治性前列腺切除术的男性中进行。然而,根治性前列腺切除术本身可能会对这些肿瘤标志物的血清浓度产生重大影响(例如围手术期液体转移或失血)。我们研究的目的是确定fPSA和tPSA的半衰期,特别关注根治性前列腺切除术对这些肿瘤标志物血清浓度的影响。

方法

对11名患有局限性前列腺癌且接受了根治性前列腺切除术的男性(平均年龄63.2±7.2岁)进行了研究(最终病理分期为pT2pN0或更低)。术前以及前列腺切除术后0.25、0.5、1、2、4、8、12、16、24、48、72、120、168和240小时采集血清样本。测定所有样本中的fPSA、tPSA以及白蛋白和总蛋白血清浓度。

结果

在前列腺切除术后的前120分钟内,白蛋白和总蛋白血清浓度持续下降,半衰期分别为-104.5±28分钟和-129.7±32分钟。fPSA和tPSA的血清下降遵循双相动力学。在初始的α期,fPSA和tPSA血清浓度下降,半衰期分别为-69±10.3分钟和-87.3±18.1分钟。在终末的β期,fPSA和tPSA的半衰期分别为-1152.2分钟(0.8天)和-3916.1分钟(2.7天)。在fPSA或tPSA的α期半衰期与总蛋白或白蛋白浓度下降的半衰期之间发现了显著相关性。

结论

这些相关性表明,前列腺切除术后fPSA和tPSA的快速下降(α期半衰期)是由根治性前列腺切除术本身引起的。β期的半衰期反映了PSA的生物清除率。因此,如果不考虑手术本身对血清PSA浓度的影响,根治性前列腺切除术后PSA半衰期的测定价值有限。

相似文献

1
Serum half-life time determination of free and total prostate-specific antigen following radical prostatectomy--a critical assessment.前列腺癌根治术后游离及总前列腺特异性抗原的血清半衰期测定——一项批判性评估
Urology. 1999 Apr;53(4):722-30. doi: 10.1016/s0090-4295(98)00593-7.
2
Comparison of serum prostate specific membrane antigen, prostate specific antigen, and free prostate specific antigen levels in radical prostatectomy patients.前列腺癌根治术患者血清前列腺特异性膜抗原、前列腺特异性抗原及游离前列腺特异性抗原水平的比较
Cancer. 1997 Jul 1;80(1):107-14. doi: 10.1002/(sici)1097-0142(19970701)80:1<107::aid-cncr14>3.0.co;2-1.
3
Risk assessment for biochemical recurrence prior to radical prostatectomy: significant enhancement contributed by human glandular kallikrein 2 (hK2) and free prostate specific antigen (PSA) in men with moderate PSA-elevation in serum.根治性前列腺切除术前行生化复发风险评估:血清前列腺特异抗原(PSA)中度升高男性中,人组织激肽释放酶2(hK2)和游离前列腺特异抗原(PSA)对显著增强风险评估有重要作用。
Int J Cancer. 2006 Mar 1;118(5):1234-40. doi: 10.1002/ijc.21474.
4
Human glandular kallikrein 2 levels in serum for discrimination of pathologically organ-confined from locally-advanced prostate cancer in total PSA-levels below 10 ng/ml.血清中人腺激肽释放酶2水平用于在总前列腺特异抗原水平低于10 ng/ml时鉴别病理局限于器官的前列腺癌与局部进展性前列腺癌。
Prostate. 2001 Oct 1;49(2):101-9. doi: 10.1002/pros.1123.
5
Volume indexes of total, free, and complexed prostate-specific antigen enhance prediction of extraprostatic disease extension in men with nonpalpable prostate cancer.总前列腺特异性抗原、游离前列腺特异性抗原和复合前列腺特异性抗原的体积指数可增强对不可触及前列腺癌男性患者前列腺外疾病扩展的预测。
Urology. 2003 Dec;62(6):1058-62. doi: 10.1016/j.urology.2003.07.016.
6
Human glandular kallikrein as a tool to improve discrimination of poorly differentiated and non-organ-confined prostate cancer compared with prostate-specific antigen.与前列腺特异性抗原相比,人腺体激肽释放酶作为一种改善低分化和非器官局限性前列腺癌鉴别诊断的工具。
Urology. 2000 Apr;55(4):481-5. doi: 10.1016/s0090-4295(99)00611-1.
7
Free/Total PSA (F/T ratio) kinetics in patients with clinically localized prostate cancer undergoing radical prostatectomy.接受根治性前列腺切除术的临床局限性前列腺癌患者的游离/总前列腺特异性抗原(F/T比值)动力学
Clin Chim Acta. 2005 Jul 24;357(2):196-201. doi: 10.1016/j.cccn.2005.03.027.
8
Half-life determination of serum free prostate-specific antigen following radical retropubic prostatectomy.
Urology. 1996 Dec;48(6A Suppl):40-4. doi: 10.1016/s0090-4295(96)00608-5.
9
Use of various combinations of free, complexed and total prostate-specific antigen levels as predictors of the pathologic stage of prostate cancer.使用游离、复合及总前列腺特异性抗原水平的各种组合作为前列腺癌病理分期的预测指标。
Int J Urol. 2001 Aug;8(8):438-43. doi: 10.1046/j.1442-2042.2001.00351.x.
10
Serum percent free prostate-specific antigen in metastatic prostate cancer.转移性前列腺癌中血清游离前列腺特异性抗原百分比
Urology. 1998 Sep;52(3):366-71. doi: 10.1016/s0090-4295(98)00240-4.

引用本文的文献

1
Persistent Prostate-Specific Antigen Following Radical Prostatectomy for Prostate Cancer and Mortality Risk.前列腺癌根治术后前列腺特异性抗原持续存在与死亡风险
JAMA Oncol. 2025 May 1;11(5):502-510. doi: 10.1001/jamaoncol.2025.0110.
2
Prediction of biochemical failure using prostate-specific antigen half-life in patients with adverse pathologic features after radical prostatectomy.根治性前列腺切除术后病理特征不良的患者中,利用前列腺特异抗原半衰期预测生化失败。
World J Urol. 2019 Jul;37(7):1321-1328. doi: 10.1007/s00345-018-2531-0. Epub 2018 Oct 22.
3
Prostate cancer in renal transplant recipients.
肾移植受者中的前列腺癌
Int Braz J Urol. 2017 Nov-Dec;43(6):1021-1032. doi: 10.1590/S1677-5538.IBJU.2016.0510.
4
Tissue-scale, personalized modeling and simulation of prostate cancer growth.前列腺癌生长的组织尺度、个性化建模与模拟
Proc Natl Acad Sci U S A. 2016 Nov 29;113(48):E7663-E7671. doi: 10.1073/pnas.1615791113. Epub 2016 Nov 16.